ddrg/super_eurlex huggingface dataset:
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 26.5.2020  
C(2020)  3537 final  
PUBLIC VERSION 
To the notifying party 
Subject : Case M. 9814 – FIRMENICH / LES DÉRIVÉS RÉSINIQUES ET 
TERPÉNIQUES  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 29 April 2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which  Firmenich  
Group (‘Firmenich’, Switzerland)  acquires  within the meaning of Article 3(1)(b) of 
the Merger Regulation control over the whole of Les Dérivés Résiniques et 
Terpéniques group (‘DRT’, France)  by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
− Firmenich specializes in the production and commercialisation of fragrances, 
flavours and aroma chemicals ; 
− DRT is mainly active in the production and commercialization of pine resin, pine 
turpentine oil and pine terpene. Some of D RT’s products can be used as aroma 
chemicals for the production of fragrances. 
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5( c) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No  139/2004.4 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p . 3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 152, 07.5.2020, p. 5. 
4  OJ C 366, 14.12.2013, p. 5.  

2 4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the noti fied operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission 
 
 
(Signed)  
Olivier GUERSENT  
Director -General
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERG ER-REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels,  17.6.2020  
C(2020 ) 4135 final  
PUBLIC VERSION  
To the notifying party  
Subject : Case M.9850 - EQT FUND MANAGEMENT / SCHÜLKE & MAYR  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 25 May 2020 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which EQT VIII 
(“EQT” ), controlled by EQT Fund Management S.à r.l.  (“EFMS”, Luxemburg) , 
acquires  within the meaning of Article 3 (1)(b) of the Merger Regulation,  sole control 
of the whole of Schülke & Mayr GmbH (“Schülke”, Germany).  The concentration is 
accomplished by way of purc hase of shares.3 
2. The business activities of the undertakings concerned are:  
 For EFMS . EQT is an investment fund that seeks to make investments 
primarily in Europe, with a focus on Northern Europe.  
 For Schülke. Schülke is active in infection prevention and hygiene. Schülke 
develops, produces and distributes antiseptics for wound care, disinfectants, 
medical and cosmetic skin care products and preservatives.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
paragraph 5 (c) of the Commission  Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 183, 03.06.2020 , p. 6. 
4  OJ C 366, 14.12.2013, p. 5 . 

2 4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in applic ation of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles , BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229- 64301. E -mail: COMP -MERG ER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels,  06.05.2020 
C(2020)  3069 final  
PUBLIC VERSION  
To the notifying parties  
Subject : Case M.9816 - ADVENT / TA / CONSERVICE  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 07 April 2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which the 
undertakings  Advent Internatio nal Corporation (“Advent”, USA)  and TA Associates 
L.P. (“TA”, USA) , acquire , within the meaning of Article 3(1)(b) and Article 3(4) of 
the Merger Regulation , joint control over the whole of the undertaking  Conservice 
LLC (“Conservice ”, U SA) controlled by TA, by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
− for Advent: (i) the acquisition of equity stakes in companies, and (ii) the 
mangement of investment funds in various sectors including industrial retail, 
media, communications, information technology, internet, healthcare and 
pharmaceuticals.  
− for TA: private equity investment activities in selected industries including 
business services, consumer, financial services, healthcare and technology.  
− for Conservice: the provision of utility management and billing software to 
property owners, residents and utility providers in the USA and Canada. 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The termino logy 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 124 , 17.04.2020 , p.23. 

2 3. After examination of the notification, the European Commission has concluded that 
the notified o peration falls within the scope of the Merger  Regulation  and of 
paragraph 5 (a) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004.4 
4. For the reasons set out in the Notice on a  simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission 
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5 .
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels, 25.9.2020  
C(2020 ) 6740 final  
PUBLIC VERSION  
To the notifying parties  
Subject : Case M. 9906  – KKR  / HPS / MONLEASING HOLDCO  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 2 September 2020 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which  KKR & Co. 
Inc. (“KKR”, United States ) and HPS Investment Partners, LLC (“HPS”, United 
States) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint 
control of the whole of Monleasing Holdco Pty Ltd  (“Monleasing ”, Australia ) from 
Monash Private Capit al Pty Ltd.  by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
 for KKR: global investment firm, which offers a broad range of alternative asset 
funds and other investment products to investors and provides capital mar kets 
solutions for the firm, its portfolio companies and other clients,  
 for HPS: US -based investment firm that focuses on acquisitions and strategic 
financing or recapitalisation of companies that require financial assistance,  
 for Monleasing: active in the  commercial and industrial equipment rental and 
leasing industry exclusively in Australia and New Zealand.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulat ion and of 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout th is decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 300,10.9.2020 , p.8. 

2 paragraph 5(a) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agre ement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
 
 
                                                 
4  OJ C 366, 14.12.2013, p. 5 .
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels, 13.10.2020  
C(2020 ) 7128 final  
PUBLIC VERSION  
To the notifying parties  
Subject : Case M. 9965  – ECP CONTROLCO / FIRST SENTIER INVESTORS / 
TERRA -GEN POWER HOLDINGS II  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 21 September 2020 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which the 
undertakings ECP ControlCo, LLC ( ‘ECP’, USA ), and First Sentier Investors (US) 
Infrastructure GP LLC  (‘FSI’, USA ), ultimately controlle d by Mitsubishi UFJ 
Financial Group Inc  (‘MUFG’, Japan ) acquire within the meaning of Article 3(1)(b)  
and 3(4)  of the Merger Regulation joint control over the whole of the undertaking  
Terra -Gen Power Holdings II, LLC  (‘TG’, USA), currently under the sole control of 
ECP by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
— for ECP: private equity investing, focusing on investing in existing and new -
build energy infrastructure project s in North America,  
— for FSI: asset management on behalf of clients such as institutional investors, 
pension funds, wholesale distributors and platforms, financial advisers and their 
clients,  
— for TG: owning, operating and developing renewable and clean ene rgy assets . 
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 321, 29.9.2020 , p. 46. 

2 paragraph 5 (a) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agre ement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
 
                                                 
4  OJ C 366, 14.12.2013, p. 5 .
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels,  3.9.2020  
C(2020)  6180 final  
PUBLIC VERSION 
To the notifying parties  
Subject : Case M. 9922 – GHO / MIC / Envision  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 10 August  2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which GHO Capital 
Fund II LP (‘GHO’, Cayman Islands)  and Mubadala Investment Company PJSC 
(‘Mubadala’, United Arab Emirates)  acquire within the  meaning of Article 3(1)(b) 
and 3(4) of the Merger Regulation joint control of  the whole of  Envision Pharma 
Group Limit ed (‘Envision’, United Kingdom)  by way of purchase of shares .3 
2. The business activities of the undertakings concerned are:  
− GHO: private equity firm focused on making buyout and growth equity 
investments in Europe in the healthcare industry , 
− Mubadala: company investing globally and actively managing a diversified 
portfolio across a variety of sectors , 
− Envision: medical consultancy and software company . 
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under  Council Regulation (EC) No  139/2004.4 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 273, 18.08.2020 , p. 4. 
4  OJ C 366, 14.12.2013, p. 5.  

2 4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission 
 
 
(Signed)  
Olivier GUERSENT  
Director -General
Commission européenne, DG  COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229 -91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu . 
  EUROPEAN COMMISSION  
Brussels, 04.11.2020  
C(2020 ) 7700 final  
PUBLIC VERSION  
To the notifying parties  
Subject : Case M.9861  –UNILABS  / MEDBASE / JV  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No 139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 7 October 2020 , the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which Unilabs  
Holding AB (“Unilabs”, Sweden) and Medbase  AG (“Medbase”, Switzerland ) acquire 
within the meaning of Article 3(1)(b)  and 3(4) of the Merger Regulation joint control 
of a newly created company constituting a joint venture (“the JV”)  by way of purchase 
of shares .3 
2. The b usiness activities of the undertakings concerned are:  
 for Unilabs : provision of bio -medical testing services, medical imaging services, 
reproductive medicine services and drug development services in a number of 
European countries , 
 for Medbase : provision of medical and therapeutic services  exclusively in 
Switzerland,  
 the JV:  provi sion of  medical laboratory diagnostics services exclusively in 
Switzerland and predominantly in Eastern Switzerland . 
3. After examination of the notification, the European Commission  has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 342, 14.10.2020 , p. 36. 

2 paragraph 5 (a) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No 139/2004 .4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in applicat ion of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agreement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
 
                                                 
4  OJ C 366, 14.12.2013, p.  5.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP M ERGER REGISTRY, 1049 Brussel,  BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 22.12.2020 
C(2020)  9605 final  
PUBLIC VERSION 
To the notifying party  
Subject : Case M.9983 – MA GNA / GFT BORDEAUX  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 30 November  2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 and following a re ferral pursuant to Article 4(5) of 
the Merger  Regulation by which Magna Powertrain  GmbH (Austria) intends to 
acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control 
over the GFT Bordeaux Production Plant (the “ GFT Bordeaux”, France), belonging to 
GETRAG FORD Tran smissions GmbH (“GFT”, Germany) , which is jointly 
controlled by Magna International Inc. (“MAGNA”, Canada)  and Ford Motor 
Company ("FORD" , USA) , by way of purchase of assets.3 
2. The business activities of the undertakings concerned are:  
− MAGNA is a global automotive supplier, which designs, develops, manufactures 
and supplies automotive systems, assemblies, modules and components primarily 
for original equipment manufacturers of passenger cars and light commercial 
vehicles,  
− The GFT Bordeaux Plant  is a manuf acturing plant for manual transmissions 
located in Bordeaux, France, and currently operated by GFT.  
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1  December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘ Community ’ by ‘Union ’ and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout thi s decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 424, 8.12.2020 , p. 37. 

2 3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraphs  5(d) and 21(b)  of the Commission Notice on a simplified procedure for 
treatment of certain concentrations under Council Regulation (EC) No  139/2004.4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation and Article 57 of 
the EEA Agre ement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5.